Crescent Biopharma, Inc. · NASDAQ:CBIO
Scalzo Richard William sold 568 Crescent Biopharma, Inc. shares (Form 4)
Traded Sep 16, 2026 · Filed Sep 18, 2026
On Sep 16, 2026, Scalzo Richard William (Chief Financial Officer) sold 568 Crescent Biopharma, Inc. shares at US$17.90 for US$10,167 under a trading plan, leaving 19,730 shares. Filed Sep 18, 2026 (Form 4).
- Sold
- 568 shares
- Price
- US$17.90
- Value
- US$10,167
- Holding after
- 19,730 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Ordinary Shares | Sale | 568 | US$17.90 | 19,730 | Direct |
Source
Related
- Crescent Biopharma, Inc.
- Scalzo Richard William
- Crescent Biopharma, Inc. shareholders
- Form 4 · Scalzo Richard William · Jun 23, 2026
- Form 4 · Brumm Joshua T · Sep 18, 2026
- Form 4 · McNeill Jonathan · Sep 18, 2026
- Form 4 · Lynch Ryan · Sep 18, 2026
- Form 4 · Pinkas Jan · Sep 18, 2026
- Form 4 · Im Ellie Eunkyung · Sep 18, 2026